The Human Immunodeficiency Virus (HIV) takes advantage of the host cell cytoskeleton machinery for infection. The identification of cellular proteins interacting with proteins of HIV during its life cycle is important for the identification of new targets for therapeutic intervention. To achieve this, genome-wide shRNA screenings will be performed in HIV infected peripheral blood lymphocytes CD4+ and monocytes.